Abstract
A novel synthetic reaction was employed to produce an acridine derivative of 4-ethyl acridine-1,3,9 (2,4,10H)-trione. The structural characterizations of the synthesized compound were confirmed through FT-IR, NMR 1H,13C, and GC-Mass spectral data. Furthermore, the DFT approaches were performed to the vibrational wavenumbers obtained through simulation with experimental wave numbers. The Vibrational Energy Distribution Analysis (VEDA) software is employed in FT-IR wave number for conducting potential energy decomposition (PED) analysis. DFT calculations were also applied to optimize the structural parameters and investigate Frontier molecular orbitals (FMOs), molecular electrostatic potentials, RDG studies, and global chemical reactivity descriptors, Natural bond orbital analysis and Non-linear optical properties were obtained for the title compound using the DFT method. Molecular docking studies were conducted to explore the binding mode mechanism of title compound and were evaluated for cancer-related proteins, specifically 4y72. Also, the synthesised compound was evaluated for Drug-likeness, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties indicating favourable pharmacokinetic profiles with no observed signs of toxicity.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
